Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · New Jersey
Novartis Pharmaceutical Sales Force
East Hanover, NJ · ~3,396 workers · 7 years of OSHA Injury Tracking Application data.
- D
- Poor Safety Record
- 4.5
- Avg TCR
- 3.3
- Industry avg
- 1
- Fatality
The verdict
Novartis Pharmaceutical Sales Force runs at 138% of its industry's injury rate - more dangerous than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade D.
- D
- Poor Safety Record
- 4.5
- avg TCR · per 100 workers
- 3.3
- industry benchmark (BLS)
- 1
- worker fatalities on record
Grade compares Novartis Pharmaceutical Sales Force's OSHA Total Case Rate of 4.5 to the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark of 3.3 (138% of benchmark) across 7 years of Form 300A filings (2016–2024). <a href="/methodology">See methodology</a> for reporting-limitation caveats.
Injury rate over time
Novartis Pharmaceutical Sales Force's yearly Total Case Rate, against the 3.3 industry benchmark.
Where Novartis Pharmaceutical Sales Force falls in its industry
959 Pharmaceutical preparations (e establishmentsSafer than 14% of graded establishments in this industry, whose median TCR is 1.4.
Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #99 safest of 108 Pharmaceutical preparations (e employers in New Jersey.
Trend analysis for Novartis Pharmaceutical Sales Force
Between 2018 and 2024, Novartis Pharmaceutical Sales Force's Total Case Rate worsened from 1.2 to 13.5 recordable injuries per 100 full-time workers, a 1046% increase across 6 years of OSHA reporting.
The safest year on record was 2020, at a TCR of 0.4, while 2024 saw the highest rate, at 13.5, a spread of 13.1 points between the best and worst reporting years. That's a wide swing relative to the establishment's overall rate, worth checking the year-by-year table below for whether a single severe year is driving the average, rather than a sustained trend.
Summed across those 7 reporting years, Novartis Pharmaceutical Sales Force recorded 163 total injuries and illnesses and 1 fatality. Readers comparing establishments should weigh the 7-year trend above alongside establishment size, since a larger workforce naturally accumulates more raw incidents even at a lower per-100-worker rate.
Verify This Employer with OSHA
The 163 injuries, 19 illnesses, and 1 fatality shown on this page for Novartis Pharmaceutical Sales Force are sourced from its own 7 years of mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source, name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.
Verify on OSHA Establishment SearchSource: U.S. Department of Labor, OSHA Establishment-Specific Injury and Illness Data. NAICS 325412 - Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing.
DART Rate, Transparent Calculation (2024)
What is the DART rate formula?
DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.
14 DART incidents × 200,000 ÷ 325,412 hours worked = 8.60 DART
Methodology: 29 CFR 1904, OSHA Form 300A recordkeeping
Cross-Validating Context, Establishment vs Industry vs State
| Benchmark | TCR | Source |
|---|---|---|
| Novartis Pharmaceutical Sales Force (this establishment) | 4.54 | OSHA ITA Form 300A, 7-year avg |
| Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing industry avg | 3.30 | BLS IIF, NAICS 325412 |
| New Jersey state avg (all industries) | 4.90 | OSHA ITA, state-level rollup |
Industry benchmarks: Bureau of Labor Statistics, Injuries, Illnesses, and Fatalities (IIF) program
Reportable Incident Timeline
Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by Novartis Pharmaceutical Sales Force to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.
- 2024: 22 reportable incidents · 22 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2023: 32 reportable incidents · 18 injuries, 14 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2022: 13 reportable incidents · 13 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2021: 26 reportable incidents · 21 injuries, 5 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2020: 12 reportable incidents · 12 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2019: 36 reportable incidents · 35 injuries, 0 illnesses, 1 fatality - OSHA inspection records (case numbers)
- 2018: 42 reportable incidents · 42 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
Source: OSHA Inspection Information System (IMIS) - inspection case-number records
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 13.5 | 8.6 | 22 | 0 | 0 |
| 2023 | 6.8 | 4.5 | 18 | 14 | 0 |
| 2022 | 8.0 | 4.3 | 13 | 0 | 0 |
| 2021 | 0.8 | 0.5 | 21 | 5 | 0 |
| 2020 | 0.4 | 0.1 | 12 | 0 | 0 |
| 2019 | 1.0 | 0.6 | 35 | 0 | 1 |
| 2018 | 1.2 | 0.5 | 42 | 0 | 0 |
What this grade means for you
Use this grade as a relative read on Novartis Pharmaceutical Sales Force's reported OSHA injury record versus its Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing peers, not a verdict on whether any single site is safe today.
- At 138% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing benchmark, Novartis Pharmaceutical Sales Force reports more injuries than typical peers, ask specifically how the employer is reducing them. Know your rights
- Judge this record against the wider Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing sector, where injury rates vary widely, before comparing it in isolation. See the industry
- Grades reflect 2016–2024 filings; check the latest establishment record straight from OSHA, or look up a different employer. Look up another
Safety grades reflect employers' self-reported OSHA Form 300A filings from 2016 to 2024 and can lag current conditions. A grade is not a guarantee that any specific workplace is safe or unsafe today. See our methodology and disclaimer.
Frequently Asked Questions
What is Novartis Pharmaceutical Sales Force's safety grade?
How many injuries has Novartis Pharmaceutical Sales Force reported?
Similar Employers
Matched by safety record across the industry, by workforce size within New Jersey, and by nearby establishments in East Hanover - a different peer set than the category browse links below.
Similar TCR (~4.5)
Similar size (~3,396 workers)
Read our methodology - how this data is sourced, computed, and verified.
Every figure and grade on PlainSafetyScore is computed directly from OSHA's published Injury Tracking Application data and BLS industry benchmarks, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these safety grades, or report a data error. Data current as of 2016-2024 OSHA ITA release.